Pelvic Congestion Syndrome (Investigational Adjunct)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for pelvic congestion syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with no controlled trials.

Welche Evidenz existiert?

Tier C (investigational). Only anecdotal central European case reports exist. Pelvic congestion syndrome is chronic pelvic pain from ovarian and pelvic vein insufficiency with retrograde flow, most common in women who have had multiple pregnancies. Evidence-based management includes medical therapy with progestins or GnRH analogs to suppress estrogen-driven venous dilation, and (more definitively) ovarian vein embolization with reported pain-improvement rates of 75 to 95 percent. Hysterectomy with bilateral salpingo-oophorectomy is reserved for refractory cases in patients past childbearing.

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over the lower abdomen for 5 to 10 days
• Local skin infection or Aeromonas infection
• Allergic reaction to leech saliva
• Triggering of additional pelvic-vein engorgement or pain during the early-bleed phase
• Delay of evidence-based ovarian vein embolization, progestin therapy, or GnRH analog therapy
• Topical leech effects are unlikely to reach the deep pelvic venous plexus where the disease lives

Wer dies nicht in Betracht ziehen sollte

• Pregnant patients (all trimesters)
• Breastfeeding patients (relative)
• Patients with active deep vein thrombosis
• Patients with endometriosis or pelvic mass not yet worked up
• Patients on anticoagulants or with severe anemia
• Patients who have not been offered or considered ovarian vein embolization

Was Sie Ihren Kliniker fragen sollten

• Has pelvic congestion been confirmed by Doppler ultrasound, CT or MR venography, or catheter venography?
• Have other causes of chronic pelvic pain (endometriosis, fibroids, adhesions) been excluded?
• Have I been offered or considered ovarian vein embolization, which has strong evidence support?
• Have I trialed progestins or GnRH analogs?
• Where exactly will the leech be placed, and how far from the femoral vein?
• What is the realistic expected benefit given the disease lives in deep pelvic veins?

Wann dringende medizinische Versorgung suchen

• Sudden severe pelvic, abdominal, or low-back pain
• Heavy vaginal bleeding or passage of clots
• Fever above 38.0 C / 100.4 F, chills, or pelvic tenderness (rule out PID)
• New leg swelling, redness, or tenderness (rule out DVT)
• Bleeding from a bite site lasting more than 24 hours
• Spreading redness, warmth, pus, or red streaks around any bite site